3 PRs? I like it. Kinda like going on a PR diet la
Post# of 142698
I think NP has been reading the posts of a few here lately because at the end of the HIV PR his statement "Leronlimab is a powerful product in the hands of a very capable team."... caught my attention.
Recknor seems like a pretty sharp dude, but I don't know how they plan on keeping all the indications moving forward. Yes they got 50 million recently, but pretty sure that has to be paid back, although I think it's in shares lately. Oh well, I guess we'll see what has NP excited about the potential use of leronlimab in severe/LH population.
Take out that word potential...then I'm excited.